UK cancer survival rates, spending lag Europe

Key points
- Cancer death rates are falling in Britain but the chances of surviving the disease are still worse than the European average and there has been little progress in closing the gap, according to a report on cancer on Wednesday.
- England spends 5.6 percent of its public healthcare budget on cancer, compared to 7.7 percent in France, 9.2 percent in the United States and 9.6 percent in Germany, the report by the London-based think-tank the Policy Exchange said, and the cancer death rate is about 6 percent higher than the European average.
- It also found that spending on cancer medicines in England - whose health figures are monitored separately from other parts of Britain - is around 60 percent of that in other advanced European countries.
- "Over the next ten years, tens of thousands of lives could be saved by improving cancer care to levels on a par with the best European countries," said Henry Featherstone, head of Policy Exchange's health unit and author of the report.
Cancer death rates are falling in Britain but the chances of surviving the disease are still worse than the European average and there has been little progress in closing the gap, according to a report on cancer on Wednesday.
England spends 5.6 percent of its public healthcare budget on cancer, compared to 7.7 percent in France, 9.2 percent in the United States and 9.6 percent in Germany, the report by the London-based think-tank the Policy Exchange said, and the cancer death rate is about 6 percent higher than the European average.
It also found that spending on cancer medicines in England - whose health figures are monitored separately from other parts of Britain - is around 60 percent of that in other advanced European countries.
"Over the next ten years, tens of thousands of lives could be saved by improving cancer care to levels on a par with the best European countries," said Henry Featherstone, head of Policy Exchange's health unit and author of the report.
He said that with earlier diagnosis and better targeting of resources towards older people and communities most at risk, authorities could make significant reductions in death rates, saving billions of pounds and averting the suffering caused to thousands of patients and families.
The report, found the current cost of cancer is just over 18 billion pounds a year in England and could rise to as much as 25 billion pounds in the next decade.
Included in those costs, were healthcare costs including hospices, costs to family and patient, and losses in productivity from cancer patients and from those who die.
The report blamed late diagnosis, poor survival rates among older and more deprived people and relatively limited uptake of new treatments as the main reasons for the higher death rate.
But it said if survival rates were improved to rank alongside the best in Europe "the savings - both in terms of lives and costs to society - would be huge", with more than 10 billion pounds saved accumulatively by 2020 and around 71,500 lives saved.
The report called on health authorities to identify and adopt best practices in cancer services from the highest-performing European countries and to focus funds on earlier diagnosis and better treatments for older deprived people. It also emphasised the importance of prevention strategies, including anti-smoking initiatives.
LONDON (Reuters)
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsNew smart robot accelerates cancer treatment research
A new smart research robot accelerates research on cancer treatments. The new robot system finds optimal treatment combinations. Today Scientific Reports (Nature Publishing Group) is publishing an article about the…
23 September 2015
NewsBiomarker helps predict survival time in gastric cancer patients
Gastric cancer poses a significant health problem in developing countries and is typically associated with late-stage diagnosis and high mortality. A new study in The American Journal of Pathology points to a pivotal…
9 September 2015
NewsTGen study finds genes associated with improved survival for pancreatic cancer patients
A study by the Translational Genomics Research Institute (TGen) and other major research institutes, found a new set of genes that can indicate improved survival after surgery for patients with pancreatic cancer. The…






